[Hypomagnesemia related to the use of omeprazole with negative result for mutation in the TRPM6 gene].
Francisco José
FJ
Fernández-Fernández
Pascual
P
Sesma
Tamara
T
Caínzos-Romero
Lucía
L
Ferreira
D000368:Aged; D000437:Alcoholism / Q000150:complications; D004942:Esophagitis, Peptic / Q000188:drug therapy; D015738:Famotidine / Q000627:therapeutic use; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects* / Q000502:physiology; D008274:Magnesium / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D008275:Magnesium Deficiency / Q000097:blood / Q000139:chemically induced* / Q000235:genetics; D008297:Male; D009853:Omeprazole / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D011110:Polymorphism, Genetic; D054328:Proton Pump Inhibitors / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D050053:TRPM Cation Channels / Q000235:genetics*; D013746:Tetany / Q000139:chemically induced
D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors; D050053:TRPM Cation Channels; C459082:TRPM6 protein, human; D015738:Famotidine; D008274:Magnesium; D009853:Omeprazole